跳至主要内容
临床试验/NL-OMON48291
NL-OMON48291已完成不适用

The interaction of Cognitive Control Mechanisms and Language Processing: An Investigation with Methylphenidate - Cognitive Control & Language

Radboud Universiteit Nijmegen0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Healthy volunteers between 18 and 45 years old;
  • Native Dutch speakers.
  • Right-handed

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • (History of) psychiatric treatment;
  • (History of) psychosis or mania;
  • (History of) neurological diseases (e.g. Parkinson, epilepsie);
  • (History of) neurological treatment;
  • (History of) endocrine treatment;
  • (History of) cardiac or vascular diseases;
  • (History of) blood illness (e.g. anemia, porphyria);
  • (History of) endocrine / metabolic disease;
  • (History of) of stomach or gastrointestinal tract disease;
  • (History of) vasovagale reflex syncope;
  • Experience of irregular sleep-wake rhythm;
  • (History of) obstructive respiratory disease
  • (History of) frequent autonomic failure (e.g. vasovagal reflex syncope);
  • (History of) clinically significant renal or hepatic disease;
  • (History of) epilepsy in adulthood (i.e. no insult after 18 years of age, no current medication for epilepsy, and no insult in the last five years);
  • (History of) glaucoma;
  • (History of) drug addication (e.g. opiate, (meth)amphetamine, lysergic acid diethylamide, cocaine, solvents or barbiturate) or alcohol dependence;
  • One first degree or two or more second degree family members with a history of sudden death or ventricular arrhythmia;
  • Problems slicking or problems with the esophagus ();
  • Frequent experience of headrush (vertigo);
  • Past or current treatment of hyperthyroidism;
  • Current experience of an acute infection (e.g. fever);
  • First degree family member with schizophrenia or bipolar disorder;
  • Abnormal hearing or (uncorrected) vision;
  • Use of psychotropic medication or recreational drugs weekly or more over a period of more than three months in the last 6 months;
  • Use of drug within 2 weeks prior to the start of the study;
  • Use of alcohol within the last 24 hours before each test session;
  • Dependence on cannabis or weekly cannabis usage for the last 6 months;
  • Strong smoking behaviour starting at more than 1 package of cigarettes per week;
  • Hypersensitivity for e.g. beta blockers or methylphenidate;
  • Previous use of Methylphenidate (Ritalin);
  • Uncontrolled hypertension, defined as diastolic blood pressure at rest >95 mmHg or systolic blood pressure at rest >180 mmHg;
  • Irregular sleep/wake rhythm (e.g. regular nightshifts or cross timeline travel);
  • Possible pregnancy or breastfeeding;
  • Lactose intolerance (because the placebo pill will be a lactose product);
  • Language related disabilities (e.g. dyslexia, stuttering);
  • Daily intense physical training.

研究者

相似试验